查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591797

止血劑和組織密封劑市場：按產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年止血劑和組織密封劑市場規模為105億美元，預計2024年將達到117.8億美元，複合年成長率為12.33%，預計到2030年將達到237.2億美元。

止血劑和組織密封膠市場由用於在外科手術過程中控制出血並幫助傷口縫合和組織粘連的設備和試劑來定義。醫療保健領域需要這些產品來最大限度地減少術中失血、減少併發症並縮短患者的康復時間。這些產品應用於各種外科領域，包括心血管外科、神經外科、整形外科和一般外科。典型的最終用戶包括醫院、診所和門診手術中心。該市場的成長受到人口老化導致的外科手術增加、外科技術的進步以及全球創傷和事故案例數量增加等因素的影響。微創手術的普及對有效的止血劑和密封劑產生了巨大的需求。亞太和拉丁美洲的新興市場充滿機遇，改善的醫療基礎設施正在為業務成長開闢新的途徑。為了佔領這些市場，公司應該專注於開發功效更高、作用持續時間更短、副作用更少的產品。

主要市場統計
基準年[2023] 105億美元
預測年份 [2024] 117.8億美元
預測年份 [2030] 237.2億美元
複合年成長率（%） 12.33%

然而，市場成長並非沒有挑戰。監管障礙，特別是 FDA 和 EMA 等機構嚴格的核准流程，可能會減緩新產品的推出。此外，先進密封劑的高成本以及縫線和釘書釘等傳統產品的競爭可能會阻礙市場滲透。克服這些問題的一個主要創新領域是開發生物基止血材料，該材料有望實現生物相容性並減少免疫反應。此外，探索奈米技術來提高產品功效和交付可以提供競爭優勢。市場的本質是動態和競爭的，頻繁的產品發布和策略聯盟塑造了格局。本公司利用研發夥伴關係關係豐富產品系列併形成策略聯盟以加強市場滲透，同時專注於嚴格的臨床試驗以有效滿足監管合規性。

市場動態：快速發展的止血和組織密封劑市場的關鍵市場洞察

供需的動態交互作用正在改變止血和組織密封劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病流行及及時手術的必要性
    • 基於生物聚合物的一次性止血材料的興起
    • 透過可信賴的線上醫療設備管道提供止血材料
  • 市場限制因素
    • 外科密封外觀品質低、高成本
  • 市場機會
    • 新一代組織密封膠與止血劑簡介
    • 重點關注創傷治療和閉合管理的舉措
  • 市場挑戰
    • 止血劑和組織封閉劑使用的嚴格標準

波特的五力：駕馭止血劑和組織密封劑市場的策略工具

波特的五力架構是了解止血劑和組織密封劑市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解止血劑和組織密封劑市場的外部影響

外部宏觀環境因素在塑造止血劑和組織密封劑市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解止血劑和組織密封劑市場的競爭狀況

止血劑和組織密封劑市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣止血劑和組織密封劑市場供應商的績效評估

FPNV定位矩陣是評估止血劑和組織密封劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪止血劑和組織密封劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，止血劑和組織密封劑市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率及及時手術的必要性
      • 基於生物聚合物的一次性止血材料的興起
      • 透過可信賴的線上醫療設備管道取得止血劑
    • 抑制因素
      • 手術密封劑輪廓品質差且成本高
    • 機會
      • 新一代組織密封膠與止血劑簡介
      • 重點關注創傷治療和閉合管理的舉措
    • 任務
      • 止血劑和組織封閉劑使用的嚴格標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章止血劑與組織密封劑市場：依產品類型

  • 止血劑
    • 主動止血劑
    • 流體止血材料
    • 機械式止血鉗
  • 組織密封膠
    • 纖維蛋白膠
    • 合成密封劑

第7章止血劑與組織密封劑市場：依應用分類

  • 燒燙傷及外傷病例
  • 心血管
  • 一般外科
  • 神經學的
  • 整形外科
  • 重組手術
  • 泌尿系統

第8章止血劑和組織密封劑市場：按最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第9章美洲止血劑和組織密封劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太止血劑與組織封閉劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章：歐洲、中東和非洲止血劑和組織密封劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Olympus在歐洲市場推出Endoclot止血劑和黏膜下注射劑
    • Corza Medical 簽署正式協議收購武田製藥 Tacosil 製造業務
    • AdvaMedica 宣布 FDA 批准 Ax-Surgi 手術止血器
    • 研究團隊開發基於細胞外基質的黏合密封劑用於角膜組織重組
    • Medcura 的 LifeGel(TM) 可吸收手術止血材料獲得突破性器械稱號
    • Cresilon獲2,500萬美元A-4輪資金籌措，加速全球擴張，為人類健康市場帶來創新止血凝膠
    • 蔡司 MTLawton 新一代電外科雙極鉗獲得 FDA 批准
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Advanced Medical Solutions Group PLC
  • Aegis Lifesciences Private Limited.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • CooperSurgical, Inc.
  • CryoLife, Inc.
  • CSL Behring
  • CuraMedical BV
  • Grifols, SA
  • Hemostasis, LLC
  • Hologic, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KAKEN PHARMACEUTICAL CO., LTD.
  • KATSAN Katgut Sanayi ve Tic. AS
  • Medline Industries, LP.
  • Medtronic PLC
  • Olympus Corporation
  • Owens & Minor
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Vivostat A/S
  • Zimmer Biomet
Product Code: MRR-437E9896A591

The Hemostats & Tissue Sealants Market was valued at USD 10.50 billion in 2023, expected to reach USD 11.78 billion in 2024, and is projected to grow at a CAGR of 12.33%, to USD 23.72 billion by 2030.

The market for hemostats and tissue sealants is defined by devices and agents used to control bleeding and assist in wound closure or tissue adhesion during surgical procedures. These products are necessary in healthcare to minimize intraoperative blood loss, thereby reducing complications and improving patient recovery times. They find applications across various surgical disciplines, including cardiovascular, neurological, orthopedic, and general surgery. Key end-users include hospitals, clinics, and ambulatory surgical centers. Growth in this market is influenced by increasing surgical procedures due to an aging population, advancements in surgical techniques, and a rise in trauma and accident cases globally. The surge in minimally invasive procedures has created significant demand for effective hemostatic and sealing agents. Opportunities abound with emerging markets in Asia-Pacific and Latin America, where healthcare infrastructure improvements open new avenues for business growth. Companies should focus on developing products with enhanced efficacy, quicker action times, and reduced side effects to capture these markets.

KEY MARKET STATISTICS
Base Year [2023] USD 10.50 billion
Estimated Year [2024] USD 11.78 billion
Forecast Year [2030] USD 23.72 billion
CAGR (%) 12.33%

However, market growth is not without challenges. Regulatory hurdles, particularly stringent approval processes from bodies like the FDA and EMA, can delay the introduction of new products. Additionally, high costs associated with advanced sealants and competition from traditional products like sutures and staples can hinder market penetration. To overcome these, key areas of innovation include the development of bio-based hemostats, which promise biocompatibility and reduced immune responses. Moreover, exploration into nanotechnology for improved product efficacy and delivery can provide competitive advantages. As for the market's nature, it is dynamic and competitive, with frequent product launches and strategic collaborations shaping its landscape. Companies are advised to leverage partnerships for R&D to boost product portfolios and engage in strategic alliances to enhance market reach while focusing on rigorous clinical trials to meet regulatory compliance efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic disorders and need for timely surgeries
    • Rise of biopolymer-based disposable hemostats
    • Availability of hemostats through trusted online medical device channels
  • Market Restraints
    • Low outlining quality and high costs of surgical sealants
  • Market Opportunities
    • Introduction of new-generation tissue sealants and hemostatic agents
    • Initiatives focusing on wound healing and closure management
  • Market Challenges
    • Strict standards regarding the utilization of hemostats & tissue sealants

Porter's Five Forces: A Strategic Tool for Navigating the Hemostats & Tissue Sealants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemostats & Tissue Sealants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemostats & Tissue Sealants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemostats & Tissue Sealants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemostats & Tissue Sealants Market

A detailed market share analysis in the Hemostats & Tissue Sealants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemostats & Tissue Sealants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemostats & Tissue Sealants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemostats & Tissue Sealants Market

A strategic analysis of the Hemostats & Tissue Sealants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgut Sanayi ve Tic. A.S., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Hemostats and Tissue sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue sealants is further studied across Fibrin Sealants and Synthetic Sealants.
  • Based on Application, market is studied across Burn & Trauma Cases, Cardiovascular, General Surgeries, Neurological, Orthopedic, Reconstructive Surgeries, and Urological.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders and need for timely surgeries
      • 5.1.1.2. Rise of biopolymer-based disposable hemostats
      • 5.1.1.3. Availability of hemostats through trusted online medical device channels
    • 5.1.2. Restraints
      • 5.1.2.1. Low outlining quality and high costs of surgical sealants
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new-generation tissue sealants and hemostatic agents
      • 5.1.3.2. Initiatives focusing on wound healing and closure management
    • 5.1.4. Challenges
      • 5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemostats & Tissue Sealants Market, by Product Type

  • 6.1. Introduction
  • 6.2. Hemostats
    • 6.2.1. Active Hemostats
    • 6.2.2. Flowable Hemostats
    • 6.2.3. Mechanical Hemostats
  • 6.3. Tissue sealants
    • 6.3.1. Fibrin Sealants
    • 6.3.2. Synthetic Sealants

7. Hemostats & Tissue Sealants Market, by Application

  • 7.1. Introduction
  • 7.2. Burn & Trauma Cases
  • 7.3. Cardiovascular
  • 7.4. General Surgeries
  • 7.5. Neurological
  • 7.6. Orthopedic
  • 7.7. Reconstructive Surgeries
  • 7.8. Urological

8. Hemostats & Tissue Sealants Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Hemostats & Tissue Sealants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats & Tissue Sealants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
    • 12.3.2. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
    • 12.3.3. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.4. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
    • 12.3.5. Medcura Receives Breakthrough Device Designation for its LifeGel(TM) Absorbable Surgical Hemostat
    • 12.3.6. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
    • 12.3.7. ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Advanced Medical Solutions Group PLC
  • 3. Aegis Lifesciences Private Limited.
  • 4. B. Braun SE
  • 5. Baxter International Inc.
  • 6. Becton, Dickinson and Company
  • 7. Cardinal Health, Inc.
  • 8. CooperSurgical, Inc.
  • 9. CryoLife, Inc.
  • 10. CSL Behring
  • 11. CuraMedical B.V.
  • 12. Grifols, S.A.
  • 13. Hemostasis, LLC
  • 14. Hologic, Inc.
  • 15. Integra LifeSciences Corporation
  • 16. Johnson & Johnson Services, Inc.
  • 17. KAKEN PHARMACEUTICAL CO., LTD.
  • 18. KATSAN Katgut Sanayi ve Tic. A.S.
  • 19. Medline Industries, LP.
  • 20. Medtronic PLC
  • 21. Olympus Corporation
  • 22. Owens & Minor
  • 23. Pfizer, Inc.
  • 24. Smith & Nephew PLC
  • 25. Stryker Corporation
  • 26. Teleflex Incorporated
  • 27. Terumo Corporation
  • 28. Thermo Fisher Scientific Inc.
  • 29. Vivostat A/S
  • 30. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY BURN & TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023